Ximing Shao

Dr. Ximing Shao

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2025 in Nature Communications
Verified
Journal Article
Open access
WHWanyi He
Wanyi He
CCCongli Chen
Congli Chen
JZJiwei Zheng
Jiwei Zheng
YLYanyan Li
Yanyan Li
HSHuaihuai Shi
Huaihuai Shi
LFLijing Fang
Lijing Fang
Targeted degradation of membrane-associated proteins, which constitute a crucial class of drug targets implicated in diverse disease pathologies, has garnered considerable attention in chemical biology and drug discovery recently. Taking advantage of the endosomal entrapment of cell-penetrating peptides (CPPs) in delivering bioactive macromolecules, we successfully construct a CPP-based platform for specific degradation of cell surface proteins by conjugation of target protein-binding small molecules (SMs) with different CPPs, resulting in the formation of CPP-mediated lysosome-targeting chimeras (CPPTACs). Through the endo-lysosomal pathway, CPPTACs exhibit a remarkable ability to degrade clinically significant plasma membrane proteins, including PD-L1, CAIX, and CB2R. In contrast to LYTACs and similar technologies, CPPTACs drive the degradation of targets in a manner independent of specific lysosome-shuttling receptors, thus providing a widely applicable strategy for plasma membrane protein degradation, regardless of the cell types. Additionally, simpler structural design and broader therapeutic window for CPPTACs are expected since CPPs-mediated endocytosis and lysosomal degradation do not necessitate the three-component binding model typically required by other heterobifunctional degraders. Overall, consisting of small molecules and biocompatible cell-penetrating peptides, CPPTACs developed in this study represent a simple, adaptable, and effective approach for selectively degrading cell surface proteins in various cellular contexts with potential for application in both biological research and therapeutic interventions.

9 January 2025 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
BCBinghua Cheng
Binghua Cheng
MLMeiqing Li
Meiqing Li
JZJiwei Zheng
Jiwei Zheng
JLJiaming Liang
Jiaming Liang
YLYanyan Li
Yanyan Li
HLHongchang Li
Hongchang Li

Verified
Journal Article
Open access
PDF file
ZZZeyu Zhou
Zeyu Zhou
JLJiaming Liang
Jiaming Liang
BCBinghua Cheng
Binghua Cheng
YLYanyan Li
Yanyan Li
WZWenjie Zhou
Wenjie Zhou
XSXiming Shao
Ximing Shao
Targeted degradation technologies, primarily referring to targeted protein degradation, have emerged as promising drug discovery strategies. In contrast to traditional “occupancy-driven” inhibition approaches, these technologies ingeniously leverage the cell’s endogenous degradation mechanisms to achieve specific elimination of disease-causing targets. Autophagy, a highly conserved cellular clearance pathway, possesses broad substrate recognition capabilities, enabling degradation of not only individual proteins but also protein aggregates, damaged organelles, and invading pathogens. Given these characteristics, researchers are actively exploring the application of autophagy mechanisms in targeted degradation technologies. Herein, we summarize recent advances in autophagy-dependent degradation approaches, including autophagosome tethering compounds (ATTEC), autophagy-targeting chimeras (AUTAC), autophagy-targeting Chimera (AUTOTAC), chaperone-mediated autophagy (CMA)-based methods, nanotechnology-based strategies, and the newly introduced autophagy-induced antibody (AUTAB) technique, highlighting their mechanisms, advantages, and potential applications in treating tumors, neurodegenerative diseases, and other challenging conditions.

7 December 2025 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
BCBichun Chen
Bichun Chen
JBJinyu Bai
Jinyu Bai
HSHuaihuai Shi
Huaihuai Shi
RHRui Hao
Rui Hao
JLJiaxin Liang
Jiaxin Liang
LFLijing Fang
Lijing Fang

22 August 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
HZHaishan Zhang
Haishan Zhang
XSXiming Shao
Ximing Shao
YPyin peng
yin peng
YTYanning Teng
Yanning Teng
Konda Mani SaravananKonda Mani Saravanan
Konda Mani Saravanan
YWYanjie Wei
Yanjie Wei
Identification of induced pluripotent stem (iPS) progenitor cells, the iPS forming cells in early stage of reprogramming, could provide valuable information for studying the origin and underlying mechanism of iPS cells. However, it is very difficult to identify experimentally since there are no biomarkers known for early progenitor cells, and only about 6 days after reprogramming initiation, iPS cells can be experimentally determined via fluorescent probes. What is more, the ratio of progenitor cells during early reprograming period is below 5%, which is too low to capture experimentally in the early stage. In this paper, we propose a novel computational approach for the identification of iPS progenitor cells based on machine learning and microscopic image analysis. Firstly, we record the reprogramming process using a live cell imaging system after 48 hours of infection with retroviruses expressing Oct4, Sox2 and Klf4, later iPS progenitor cells and normal murine embryonic fibroblasts (MEFs) within 3 to 5 days after infection are labeled by retrospectively tracing the time-lapse microscopic image. We then calculate 11 types of cell morphological and motion features such as area, speed, etc., and select best time windows for modeling and perform feature selection. Finally, a prediction model using XGBoost is built based on the selected six types of features and best time windows. Our model allows several missing values/frames in the sample datasets, thus it is applicable to a wide range of scenarios. Cross-validation, holdout validation and independent test experiments showed that the minimum precision is above 52%, that is, the ratio of predicted progenitor cells within 3 to 5 days after viral infection is above 52%. The results also confirmed that the morphology and motion pattern of iPS progenitor cells is different from that of normal MEFs, which helps with the machine learning methods for iPS progenitor cell identification. Author Summary: Identification of induced pluripotent stem (iPS) progenitor cells could provide valuable information for studying the origin and underlying mechanism of iPS cells. However, it is very difficult to identify experimentally since there are no biomarkers known for early progenitor cells, and only after about 6 days of induction, iPS cells can be experimentally determined via fluorescent probes. What is more, the percentage of the progenitor cells during the early induction period is below 5%, too low to capture experimentally in early stage. In this work, we proposed an approach for the identification of iPS progenitor cells, the iPS forming cells, based on machine learning and microscopic image analysis. The aim is to help biologists to enrich iPS progenitor cells during the early stage of induction, which allows experimentalists to select iPS progenitor cells with much higher probability, and furthermore to study the biomarkers which trigger the reprogramming process.

20 February 2026 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HTHui Tian
Hui Tian
WPWencong Pan
Wencong Pan
HSHuaihuai Shi
Huaihuai Shi
XSXiming Shao
Ximing Shao
JSJingjing Sun
Jingjing Sun
LFLijing Fang
Lijing Fang